Bulletin
Investor Alert

New York Markets Close in:

April 8, 2020, 2:04 p.m. EDT

Global Developmental Dyspraxia Drug Market: Key Players Profile Eli Lily & Company, Novartis AG, Mylan N.V., Tris Pharma, Inc, Johnson & Johnson Services, Inc

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

  • Antidepressants

  • Others

By End Users

  • Hospitals

  • Home Care Settings

  • Specialty Clinics

  • Pediatrician

  • Others

By Distribution Channel

  • Retail Pharmacies

  • Drug Stores

  • Online Pharmacies

  • Others

By Geography

  • North America

  • South America

  • Europe

  • Asia-Pacific

  • Middle East & Africa

Key Developments in the Market:

In January 2018, F. Hoffmann-La Roche Ltd received Breakthrough Therapy designation from the FDA for Balovaptan for the treatment of autism spectrum disorder (ASD). Balovaptan, vasopressin (V1a) receptor antagonist has potential to be the first ever pharmacotherapy in improve the core social interaction and communication symptoms of neurology disorders.

In December 2016, Mylan N.V. launched Methylphenidate Hydrochloride, an extended release tablet which is a generic version of Concerta for the treatment of of Attention Deficit Hyperactivity Disorder (ADHD). The launch of methylphenidate hydrochloride will significantly help patients who have neuro motor sensory impairment conditions.

Reasons to Purchase this Report

  • Current and future of global developmental dyspraxia drug market outlook in the developed and emerging markets

  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period

  • The latest developments, market shares, and strategies that are employed by the major market players

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

COMTEX_364333918/2649/2020-04-08T14:04:02

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.